BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/26/2018 8:48:04 AM | Browse: 1141 | Download: 1875
 |
Received |
|
2018-01-30 16:24 |
|
Peer-Review Started |
|
2018-01-31 01:46 |
|
To Make the First Decision |
|
2018-02-24 00:57 |
|
Return for Revision |
|
2018-02-24 02:37 |
|
Revised |
|
2018-03-02 07:01 |
|
Second Decision |
|
2018-03-16 11:04 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-03-18 01:40 |
|
Articles in Press |
|
2018-03-18 01:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-03-23 09:13 |
|
Publish the Manuscript Online |
|
2018-03-26 08:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Christian Rupp, Theresa Hippchen, Manuel Neuberger, Peter Sauer, Jan Pfeiffenberger, Wolfgang Stremmel, Daniel Nils Gotthardt, A Mehrabi and KH Weiss |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| “Deutsche Forschungsgemeinschaft” to Rupp C and Gotthardt DN |
|
|
| Corresponding Author |
Christian Rupp, MD, Attending Doctor, Department of Internal Medicine IV, University Hospital of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany. christian_rupp@med.uni-heidelberg.de |
| Key Words |
Hepatitis C virus; Recurrence; Direct acting antivirals; Liver transplantation; Sustained virological response |
| Core Tip |
We examined the safety and efficiency of novel direct-acting antiviral agents (DAAs) in liver-transplanted patients with recurrence of hepatitis c virus (HCV) infection in a real-world cohort at our tertiary care center. In conclusion, DAAs are safe and very efficient in HCV patients after liver transplantation, even in case of recurrent cirrhosis or history of relapse after pegylated-interferon therapy. The high sustained virological response rates in our cohort, despite many patients with recurrent cirrhosis, may argue for a 24-wk therapy period in patients with risk factors for therapy failure in a posttransplant setting. |
| Publish Date |
2018-03-26 08:48 |
| Citation |
Rupp C, Hippchen T, Neuberger M, Sauer P, Pfeiffenberger J, Stremmel W, Gotthardt DN, Mehrabi A, Weiss KH. Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus. World J Gastroenterol 2018; 24(12): 1353-1360 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i12/1353.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i12.1353 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
